Home › Encyclopedia › Melanotan II: Research Status And Clinical Trial Data
Research / Unapproved

Melanotan II: Research Status And Clinical Trial Data

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC50H69N15O9
Molecular weight1024.2 g/mol
Registered trials1
PubChem CID92432

What Melanotan II Is

Melanotan II is a synthetic peptide compound with the molecular formula C50H69N15O9 and a molecular weight of about 1,024 g/mol (PubChem CID 92432). It has no FDA-approved label, no approved brand name, and no established medical indication. It is currently classified as an unapproved compound under active research.

Clinical Trial Footprint

Registries currently list one clinical trial involving Melanotan II. That trial, NCT07437560, is a Phase 2 study recruiting participants to evaluate Melanotan II as an adjunct to NB-UVB phototherapy for repigmentation in people with stable nonsegmental vitiligo. Because the study is still recruiting, no outcome data are yet available from it.

FAQ

Is Melanotan II FDA approved?
No. Melanotan II has no FDA-approved label, no approved brand name, and no approved medical use. It is classified as an unapproved compound currently under research.
What is Melanotan II being studied for?
The one registered clinical trial is examining Melanotan II as an add-on to NB-UVB phototherapy for repigmentation in stable nonsegmental vitiligo. This is a Phase 2 study that is still recruiting participants, so results are not yet available.
What is the chemical makeup of Melanotan II?
Melanotan II is a synthetic peptide with the molecular formula C50H69N15O9 and a molecular weight of roughly 1,024 g/mol. Its structure and identity are catalogued under PubChem CID 92432.
Are there known side effects of Melanotan II?
There is currently no FDA adverse event report data available for this compound in the dataset reviewed. Because it lacks an approved label, no official side effect profile has been established.
How many clinical trials have studied Melanotan II?
As of the latest data pull, only one clinical trial involving Melanotan II is registered. That trial is a Phase 2 study focused on vitiligo repigmentation and is currently recruiting.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem ClinicalTrials.gov

Updated 2026-08-03